Overview
CANKADO is a prominent healthcare company with a primary focus on developing digital health applications, particularly in the field of oncology. The company positions itself as an innovative research entity, crafting solutions that aim to enhance patient safety and quality of life through advanced digital health tools. CANKADO’s offerings are designed to support personalized cancer care management, enabling patients to meticulously record medication details, monitor symptoms, and leverage AI technologies to predict health events.
Products and Services
CANKADO specializes in digital health applications for oncology care. By providing robust medical devices and digital tools, the company empowers patients to manage their symptoms and treatment more effectively. Central to its offerings is a comprehensive digital patient record system, which significantly enhances patient safety and quality of treatment. An outstanding service provided by CANKADO is CANKADO PRO-React, a solution revered for improving the quality of life for patients undergoing treatments such as HR+ HER2− metastatic breast cancer therapy.
Financials and Operations
The financial landscape of CANKADO is characterized by an estimated annual revenue of approximately $4.7 million, with a revenue per employee of around $189,000. Despite its prominent industry position, CANKADO has not engaged in formal funding rounds or attracted institutional investors as of July 2024. Headquartered in Ottobrunn, Bavaria, the company has expanded its international operations with offices in Köln, Germany, and Trivandrum, India. CANKADO employs a workforce of 25 individuals, maintaining a stable operational structure with no growth in employee numbers over the past year.
Leadership Team
- Prof. Dr. Timo Schinköthe - CEO: Known for his significant contributions to advancing oncology care through digital health innovations.
- Ashir Ashraf - Chief Global Strategist: Brings extensive expertise in business management and strategic oversight in digital health applications.
- Martin Mika - QMB/COO: Manages operational strategies and processes efficiently.
- Susmitha S - Mobile Application Developer
- Rahul D - Database Administrator
Headquarters and Locations
CANKADO's headquarters are situated in Ottobrunn, Bavaria. Its additional operational offices, located in Köln, NRW, and Trivandrum, Kerala, are instrumental in supporting its global reach and fostering innovation in the rapidly changing digital health industry.
With a specialized focus on eHealth and oncology, and a strong emphasis on AI application under ISO 27001 standards, CANKADO is committed to sustaining high standards of digital health innovation and safeguarding patient data.
Competitive Landscape
CANKADO operates in a highly competitive digital health sector. Key competitors include:
- TeleClinic: Revenue of $29.7 million, 110 employees, and a growth rate of 8%.
- Vivy: Renowned for its digital health record services with a revenue of $22.4 million, 83 employees, and a decline in growth by 11%.
- HelloBody: Competes in health and wellness, with revenue similar to CANKADO at $4.5 million and a 14% increase in workforce.
- Mika Health and Teladoc Health are notable market contenders.
CANKADO faces competition from over 300 companies worldwide, reflecting the fiercely competitive environment of the digital health sector. Nonetheless, CANKADO’s specialization in oncology care through digital solutions offers a competitive edge in the precision healthcare market. This focus, backed by efficient resource utilization and a stable workforce, ensures CANKADO's resilience and positions it as a significant player in addressing specialized healthcare needs within the digital health sector.
